Back to
Qube Research & Technologies Ltd
VVOS
Showing 0 of 2 quarters
Position history for
Qube Research & Technologies Ltd's holdings in VIVOS THERAPEUTICS INC
No. Qube Research & Technologies exited its VVOS (Vivos Therapeutics) position in Q4 2023. Its Q3 2023 13F listed 200 shares worth $38. Qube Research & Technologies first reported VVOS in Q3 2023 and held it in 1 quarterly 13F filing.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.